Agile Therapeutics to Present at Biotech Showcase™ 2020 in San Francisco
December 19 2019 - 4:05PM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare
company, today announced that it has scheduled a company
presentation at Biotech Showcase™ 2020, to be held January 14
at the Hilton San Francisco Union Square.
Chairman and Chief
Executive Officer, Al Altomari, will be presenting for Agile
Therapeutics at Biotech Showcase as follows: |
|
|
Date: |
Tuesday, January 14, 2020 |
|
|
Time: |
10:00 AM (PST) / 1:00 PM
(EST) |
|
|
Room: |
Yosemite C |
|
|
Venue: |
Hilton San Francisco Union
Square, 333 O’Farrell Street, San Francisco, CA (United
States) |
To access live and archived webcasts of the
presentation, visit the Investor Relations section of the Agile
Therapeutics website at www.agiletherapeutics.com. The webcast will
be archived on the Agile Therapeutics website for 60 days following
the event.
About Agile Therapeutics, Inc.
Agile Therapeutics is a forward-thinking women's
healthcare company dedicated to fulfilling the unmet health needs
of today’s women. Our product candidates are designed to provide
women with contraceptive options that offer freedom from taking a
daily pill, without committing to a longer-acting method. Our lead
product candidate, Twirla®, (ethinyl estradiol and levonorgestrel
transdermal system), also known as AG200-15, is an investigational,
non-daily prescription contraceptive. Twirla is based on our
proprietary transdermal patch technology, called Skinfusion®, which
is designed to allow drug delivery through the skin. For more
information, please visit the company website at
www.agiletherapeutics.com. The Company may occasionally disseminate
material, nonpublic information on the Company’s website.
Contact: Investor Relations -- 609-683-1880
Source: Agile Therapeutics, Inc.
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2023 to Apr 2024